Digital olfaction mimics the human sense of smell to deliver consistent, objective odor data so companies can transform intangible odor information into business assets that strengthen product offerings and consumer experiences. As the mobility industry offer autonomous fleets, digital olfaction provides a sensor solution to real-time odor assessment of these vehicles. These sensors provide real-time monitoring of vehicle odors to ensure vehicles meet customer expectations while performing malodor monitoring that alert fleet operations of vehicles in need of service. These integrated sensors optimize fleet maintenance while also ensuring the vehicle experience meets customer expectations.
Tristan ensures the development of global strategic partnerships and customer relationships to meet Aryballe’s long term vision for the potential of digital olfaction. Prior to founding Aryballe in 2014, Tristan was the founder and CEO of PX’Therapeutics which specialized in the development of therapeutic proteins. PX’Therapeutics was sold to Aguettan Biotech in 2012. Tristan holds a PhD in Cell Biology from Grenoble University (France).